These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37776214)

  • 21. The incremental prognostic and clinical value of multiple novel biomarkers in heart failure.
    Jackson CE; Haig C; Welsh P; Dalzell JR; Tsorlalis IK; McConnachie A; Preiss D; Anker SD; Sattar N; Petrie MC; Gardner RS; McMurray JJ
    Eur J Heart Fail; 2016 Dec; 18(12):1491-1498. PubMed ID: 27114189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of very high high-sensitivity C-reactive protein levels on mortality after stroke.
    Itrat A; Griffith SD; Alam S; Thompson N; Katzan IL
    J Neurol Sci; 2017 Jan; 372():1-5. PubMed ID: 28017191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High sensitivity C-reactive protein predicts nonresponders and cardiac deaths in severe heart failure patients after CRT implantation.
    Kamioka M; Suzuki H; Yamada S; Kamiyama Y; Saitoh S; Takeishi Y
    Int Heart J; 2012; 53(5):306-12. PubMed ID: 23038092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective cohort study of C-reactive protein as a predictor of clinical events in adults with congenital heart disease: results of the Boston adult congenital heart disease biobank.
    Opotowsky AR; Valente AM; Alshawabkeh L; Cheng S; Bradley A; Rimm EB; Landzberg MJ
    Eur Heart J; 2018 Sep; 39(34):3253-3261. PubMed ID: 30010900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-reactive protein level on admission and time to and cause of death in patients hospitalized for acute heart failure.
    Minami Y; Kajimoto K; Sato N; Hagiwara N; Takano T;
    Eur Heart J Qual Care Clin Outcomes; 2017 Apr; 3(2):148-156. PubMed ID: 28927169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study.
    Lindholm D; James SK; Gabrysch K; Storey RF; Himmelmann A; Cannon CP; Mahaffey KW; Steg PG; Held C; Siegbahn A; Wallentin L
    JAMA Cardiol; 2018 Dec; 3(12):1160-1166. PubMed ID: 30427997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The association of high-sensitivity C-reactive protein with new-onset hypertension in different age groups].
    Guo ZM; Wu JH; Li XY; Yang S; Wang GP; Wu SL; Zhang Q
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Oct; 50(10):993-999. PubMed ID: 36299222
    [No Abstract]   [Full Text] [Related]  

  • 28. Borderline Values of Troponin-T and High Sensitivity C-Reactive Protein Did Not Predict 2-Year Mortality in TnT Positive Chest-Pain Patients, Whereas Brain Natriuretic Peptide Did.
    Nilsen DW; Mjelva ØR; Leon de la Fuente RA; Naesgaard P; Pönitz V; Brügger-Andersen T; Grundt H; Staines H; Nilsen ST
    Front Cardiovasc Med; 2015; 2():16. PubMed ID: 26664888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations Between High-Sensitivity C-Reactive Protein and All-Cause Mortality Among Oldest-Old in Chinese Longevity Areas: A Community-Based Cohort Study.
    Chen PL; Li ZH; Yang HL; Cao ZJ; Cheng X; Zhao F; Zhang XR; Lv YB; Li FR; Zhou YF; Li HN; Qu YL; Yin ZX; Liu L; Wu XB; Shi XM; Mao C
    Front Public Health; 2022; 10():824783. PubMed ID: 35211447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there a C-reactive protein value beyond which one should consider infection as the cause of acute heart failure?
    Pereira J; Ribeiro A; Ferreira-Coimbra J; Barroso I; Guimarães JT; Bettencourt P; Lourenço P
    BMC Cardiovasc Disord; 2018 Feb; 18(1):40. PubMed ID: 29482547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Old markers, new approach to assessment of risk in heart failure.
    Kodziszewska K; Leszek P; Korewicki J; Piotrowski W
    Kardiol Pol; 2015; 73(6):387-95. PubMed ID: 25563469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abilities of Pre- and Postoperative High-Sensitivity C-Reactive Protein Levels to Predict 90-Day Mortality After Surgery for Abdominal and Thoracic Cancers.
    Oh TK; Choi Y; Oh AY; Chung SH; Han S; Ryu JH
    Ann Surg Oncol; 2018 Nov; 25(12):3660-3666. PubMed ID: 30178394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal High-Sensitivity C-Reactive Protein and Longer-Term Cardiovascular Outcomes in Optimally-Treated Patients With High-Risk Vascular Disease.
    Dykun I; Clark D; Carlo J; Lincoff AM; Menon V; Nissen SE; Nicholls SJ; Puri R
    Am J Cardiol; 2022 Oct; 181():1-8. PubMed ID: 35970631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel protein glycan biomarker and future cardiovascular disease events.
    Akinkuolie AO; Buring JE; Ridker PM; Mora S
    J Am Heart Assoc; 2014 Sep; 3(5):e001221. PubMed ID: 25249300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure.
    Jug B; Salobir BG; Vene N; Sebestjen M; Sabovic M; Keber I
    Heart Vessels; 2009 Jul; 24(4):271-6. PubMed ID: 19626399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The inflammatory markers sST2, HSP27 and hsCRP as a prognostic biomarker panel in chronic heart failure patients.
    Traxler D; Zimmermann M; Simader E; Veraar CM; Moser B; Mueller T; Mildner M; Dannenberg V; Lainscak M; Jug B; Ankersmit HJ
    Clin Chim Acta; 2020 Nov; 510():507-514. PubMed ID: 32735982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High high-sensitivity C-reactive protein/BMI ratio predicts future adverse outcomes in patients with acute coronary syndrome.
    Jia L; Yuan JQ; Zhu L; Zhang Y
    Coron Artery Dis; 2019 Sep; 30(6):448-454. PubMed ID: 31386638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure.
    Yin WH; Chen JW; Jen HL; Chiang MC; Huang WP; Feng AN; Young MS; Lin SJ
    Am Heart J; 2004 May; 147(5):931-8. PubMed ID: 15131554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial.
    Mani P; Puri R; Schwartz GG; Nissen SE; Shao M; Kastelein JJP; Menon V; Lincoff AM; Nicholls SJ
    JAMA Cardiol; 2019 Apr; 4(4):314-320. PubMed ID: 30840024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High osteopontin levels predict long-term outcome after STEMI and primary percutaneous coronary intervention.
    Bjerre M; Pedersen SH; Møgelvang R; Lindberg S; Jensen JS; Galatius S; Flyvbjerg A
    Eur J Prev Cardiol; 2013 Dec; 20(6):922-9. PubMed ID: 23613225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.